The consortium attended one of the leading European conferences on BBB research. The researcher Paula Schwarz presented her work on the ‚Design of novel stabilized peptide scaffolds for BBB transport‘ as Poster presentation.
The program MSCA4Ukraine will provide support to displaced researchers from Ukraine. Our consortium is wiling to supports this initiative. To discuss opportunities for this fund contact the research coordinator roland.hellinger@meduniwien.ac.at.
Further information on the program is available here.
Researchers at MedUni Vienna, Karl Landsteiner University of Health Sciences, University of Veterinary Medicine Vienna and Ludwig Boltzmann Institute for Cancer Research demonstrate an anti-tumor effect of certain nature-derived cyclic peptides.
Link to the news feed of the Medical University of Vienna.
The publication is online available : Biomedicine & Pharmacotherapy
J. Lind, R. Hellinger, P. Kudweis, H. P. Moll, J. Gattringer, K. Thell, S. Edtmayer, C. W. Gruber, D. Stoiber, K. Kollmann.
The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphoma
DOI: https://doi.org/10.1016/j.biopha.2022.113486
The research consortium presented their recent work with three poster and one oral presentation on the 36th European Peptide Symposium in Sitges, Spain. Jasmin Gattringer talked on her project „Cyclic peptides as modulators of immune cell migration“ as invited speaker for the Young Investigator Mini Symposium. Paula Schwarz, Kirtikumar Jadhav and Roland Hellinger presented posters. EPS
The researchers Eva-Maria Zangerl-Plessl (PI) and Theres Friesacher (PhD student) have contributed to the research article ‚β subunits of GABAA receptors form proton-gated chloride channels: Insights into the molecular basis‘. The study was peer reviewed and published by Communications in Biology (IF 6.5, Nature Publishing Group) and is availably onlin here.
PeptAIDes 